Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-finding study of AVP-923 for central neuropathic pain in multiple sclerosis
2011-002178-22Phase 2Completed
- Sponsor
- Avanir Pharmaceuticals
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dextromethorphan, quinidine in central neuropathic pain in multiple sclerosis, sponsored by Avanir Pharmaceuticals. Started Oct 2011; status: completed.
02
Drugs
dextromethorphanquinidine
03
Conditions
central neuropathic pain in multiple sclerosis
Beyond the preview
Go deeper on 2011-002178-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002178-22.